Insulin glargine and lixisenatide Subcutaneous and Ranitidine Capsule
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Ranitidine Capsule and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: ranitidine
Brand name: Zantac
Synonyms: Ranitidine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Ranitidine Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Ranitidine Injection
- Insulin glargine and lixisenatide Subcutaneous-Ranitidine Suspension
- Insulin glargine and lixisenatide Subcutaneous-Ranitidine Syrup
- Insulin glargine and lixisenatide Subcutaneous-Ranitidine Tablets
- Insulin glargine and lixisenatide Subcutaneous-Ranitidine Tablets and Capsules
- Ranitidine Capsule-Insulin glargine, recombinant Subcutaneous
- Ranitidine Capsule-Insulin glulisine
- Ranitidine Capsule-Insulin Glulisine (Cartridges and Pens)
- Ranitidine Capsule-Insulin Glulisine (Vials)
- Ranitidine Capsule-Insulin glulisine Subcutaneous
- Ranitidine Capsule-Insulin human inhaled Inhalation